Exagen Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Hi, it's Paul Knight, the analyst in life science and diagnostics at KeyBanc. Thanks for being here. (Conference Instructions)
We have Ron Rocca, CEO of Exagen; and Kamal Adawi, Chief Financial Officer. I thought, Ron, if you could provide -- I don't know if you have a slideshow, but or -- just a little bit of an intro for those not familiar with Exagen.
Sure. And we have slides.
Okay.
We have slides, but I think it's better if I just talk about it. So we are an autoimmune-focused company, and what that means is strictly with the rheumatologist. Our strategy, our mission if you will, is to own the hilltop. We have a very experienced executive team. And we find that that's the best way to go to market, is to have multiple assets for one specialty category and be able to deliver
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
